GlassScriptPhysician profile
Sanjeev M Balamohan
NPI 1952740318
$3,520.31
in general payments reported to CMS, 2019-2025
11 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $95.94 · 2021: $55.02 · 2022: $371 · 2023: $438 · 2024: $993 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,828.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $1,102.49 | 2024-2025 | Septalign |
| Aerin Medical INC. | $989.68 | 2019-2024 | |
| Medtronic, INC. | $717.17 | 2022-2025 | Propel, Pteye Parathyroid Detection System |
| Optinose US, INC. | $153.92 | 2022 | |
| Olympus America INC. | $141.86 | 2025 | Rhino-Laryngo Videoscope |
| Stryker Corporation | $122.82 | 2022 | |
| Genzyme Corporation | $108.49 | 2025 | |
| Intersect Ent, INC. | $77.73 | 2019-2021 | |
| Acclarent, INC | $52.28 | 2022 | |
| Boston Scientific Corporation | $38.84 | 2024 | Wavewriter Alpha Prime 16 |
| Regeneron Healthcare Solutions, INC. | $15.03 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Balamohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.